Literature DB >> 12589133

Small-for-size graft problems in adult-to-adult living-donor liver transplantation.

Yasuhiko Sugawara1, Masatoshi Makuuchi.   

Abstract

The number of adult patients undergoing living donor liver transplantation (LDLT) has recently increased. According to a recent Japanese survey, the 5-year survival rate in adults after surgery is only 69.7%, which is significantly poorer than that in pediatric series. Small-for-size grafts remain a problem in adult LDLT. The most commonly used liver graft for adult patients has shifted from the left liver to the right, which alleviates the problem of size disproportion. Right hepatectomy, however, increases the extent of the donor operation and raises an important ethical issue in LDLT. Patients who truly need a right liver graft should be carefully selected using evidence-based criteria.

Entities:  

Mesh:

Year:  2003        PMID: 12589133     DOI: 10.1097/01.TP.0000046616.76542.DF

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Estimating liver weight of adults by body weight and gender.

Authors:  See Ching Chan; Chi Leung Liu; Chung Mau Lo; Banny K Lam; Evelyn W Lee; Yik Wong; Sheung Tat Fan
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

2.  Excessive portal flow causes graft failure in extremely small-for-size liver transplantation in pigs.

Authors:  Hong-Sheng Wang; Nobuhiro Ohkohchi; Yoshitaka Enomoto; Masahiro Usuda; Shigehito Miyagi; Takeshi Asakura; Hiroo Masuoka; Takashi Aiso; Keisuke Fukushima; Tomohiro Narita; Hideyuki Yamaya; Atsushi Nakamura; Satoshi Sekiguchi; Naoki Kawagishi; Akira Sato; Susumu Satomi
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Using small-for-size grafts in living donor liver transplantation recipients with high MELD scores should not be considered a contraindication.

Authors:  Hongyu Li; Bo Li
Journal:  Dig Dis Sci       Date:  2013-07-18       Impact factor: 3.199

Review 4.  Small-for-size syndrome in living-donor liver transplantation using a left lobe graft.

Authors:  Masahiko Taniguchi; Tsuyoshi Shimamura; Satoru Todo; Hiroyuki Furukawa
Journal:  Surg Today       Date:  2014-06-05       Impact factor: 2.549

5.  Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts.

Authors:  Pei-Xian Chen; Lu-Nan Yan; Wen-Tao Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.

Authors:  James J Pomposelli; Nathan P Goodrich; Jean C Emond; Abhinav Humar; Talia B Baker; David R Grant; Robert A Fisher; John P Roberts; Kim M Olthoff; Brenda W Gillespie; Robert M Merion
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

7.  Living donor liver transplantation using dual grafts: ultrasonographic evaluation.

Authors:  Qiang Lu; Hong Wu; Lv-Nan Yan; Zhe-Yu Chen; Yu-Ting Fan; Yan Luo
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

8.  One hundred in situ split-liver transplantations: a single-center experience.

Authors:  Hasan Yersiz; John F Renz; Douglas G Farmer; Garrett M Hisatake; Suzanne V McDiarmid; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

9.  Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation.

Authors:  Hany Shoreem; Emad Hamdy Gad; Hosam Soliman; Osama Hegazy; Sherif Saleh; Hazem Zakaria; Eslam Ayoub; Yasmin Kamel; Kalid Abouelella; Tarek Ibrahim; Ibrahim Marawan
Journal:  World J Hepatol       Date:  2017-07-28

10.  Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.

Authors:  HongYu Li; Bo Li; YongGang Wei; LvNan Yan; TianFu Wen; MingQing Xu; WenTao Wang; JiaYin Yang
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.